Nifty

:

25683.30

Sensex

:

83576.24

-193.55 (-0.75%)
-604.72 (-0.72%)

Login

Nifty
Sensex

:
:

25683.30
83576.24

-193.55 (-0.75%)
-604.72 (-0.72%)

Trident Lifeline Ltd.

Pharmaceuticals & Drugs

Rating :

76/99

BSE: 543616 | NSE: Not Listed

Watchlist

NSE BSE

290.00

09-Jan-2026

Open
High
Low
Previous Close

300
300
290
295.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

3000
879120
300
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

346.06
26.51
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

402.77
N/A
4.16

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
47.78
40.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
69.85
19.11

PAT CAGR (%)

10 Years
5 Years
3 Years

-
83.34
24.94

P:E (Median)

8 Years
5 Years
3 Years

-
-
36.18

P:BV (Average)

8 Years
5 Years
3 Years

-
-
4.99

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
27.64

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 27.44 15.66 75.22% 18.82 14.74 27.68% 0.00 0.00 0 16.51 7.09 132.86%
Expenses 21.06 11.24 87.37% 13.89 10.66 30.30% 0.00 0.00 0 12.37 5.61 120.50%
EBITDA 6.38 4.42 44.34% 4.93 4.08 20.83% 0.00 0.00 0 4.14 1.48 179.73%
EBIDTM 23.26% 28.24% 26.18% 27.67% 0.00% 0.00% 25.07% 20.89%
Other Income 1.11 0.52 113.46% 0.54 0.47 14.89% 0.00 0.00 0 0.54 0.25 116.00%
Interest 0.42 0.27 55.56% 0.33 0.20 65.00% 0.00 0.00 0 0.35 0.15 133.33%
Depreciation 0.59 0.16 268.75% 0.51 0.33 54.55% 0.00 0.00 0 0.38 0.19 100.00%
PBT 6.48 4.52 43.36% 4.63 4.02 15.17% 0.00 0.00 0 3.95 1.39 184.17%
Tax 1.54 1.13 36.28% 1.15 1.01 13.86% 0.00 0.00 0 0.92 0.29 217.24%
PAT 4.94 3.39 45.72% 3.48 3.01 15.61% 0.00 0.00 0 3.03 1.11 172.97%
PATM 18.00% 21.65% 18.47% 20.45% 0.00% 0.00% 18.34% 15.61%
EPS 4.26 2.92 45.89% 3.00 2.60 15.38% 0.00 0.00 0 2.61 0.95 174.74%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 31.34 15.45 102.85% 23.61 13.15 79.54% 0.00 0.00 0 11.83 7.09 66.85%
Expenses 24.48 11.40 114.74% 18.44 10.66 72.98% 0.00 0.00 0 7.75 5.67 36.68%
EBITDA 6.86 4.05 69.38% 5.17 2.50 106.80% 0.00 0.00 0 4.08 1.42 187.32%
EBIDTM 21.88% 26.23% 21.89% 18.99% 0.00% 0.00% 34.47% 20.08%
Other Income 1.67 0.54 209.26% 1.35 1.15 17.39% 0.00 0.00 0 0.56 0.25 124.00%
Interest 0.99 0.50 98.00% 1.13 0.49 130.61% 0.00 0.00 0 0.55 0.15 266.67%
Depreciation 0.91 0.16 468.75% 1.46 0.54 170.37% 0.00 0.00 0 0.61 0.19 221.05%
PBT 6.63 3.93 68.70% 3.94 2.61 50.96% 0.00 0.00 0 3.48 1.33 161.65%
Tax 1.54 1.13 36.28% 1.15 1.01 13.86% 0.00 0.00 0 0.92 0.29 217.24%
PAT 5.09 2.81 81.14% 2.79 1.60 74.38% 0.00 0.00 0 2.56 1.05 143.81%
PATM 16.25% 18.18% 11.80% 12.17% 0.00% 0.00% 21.60% 14.80%
EPS 4.27 2.69 58.74% 2.66 1.99 33.67% 0.00 0.00 0 2.42 0.94 157.45%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Net Sales - 67.80 44.65 31.69 21.77 9.62 Net Sales Growth - 51.85% 40.90% 45.57% 126.30% Cost Of Goods Sold - 27.52 25.11 16.41 10.77 5.51 Gross Profit - 40.28 19.54 15.29 11.00 4.11 GP Margin - 59.41% 43.76% 48.25% 50.53% 42.72% Total Expenditure - 50.13 35.78 25.43 19.06 8.37 Power & Fuel Cost - 0.14 0.07 0.03 0.02 0.02 % Of Sales - 0.21% 0.16% 0.09% 0.09% 0.21% Employee Cost - 2.51 1.55 1.39 1.10 0.70 % Of Sales - 3.70% 3.47% 4.39% 5.05% 7.28% Manufacturing Exp. - 12.84 5.92 4.64 4.63 1.29 % Of Sales - 18.94% 13.26% 14.64% 21.27% 13.41% General & Admin Exp. - 1.33 1.00 0.79 0.81 0.38 % Of Sales - 1.96% 2.24% 2.49% 3.72% 3.95% Selling & Distn. Exp. - 5.00 1.43 1.75 1.62 0.45 % Of Sales - 7.37% 3.20% 5.52% 7.44% 4.68% Miscellaneous Exp. - 0.79 0.70 0.42 0.11 0.01 % Of Sales - 1.17% 1.57% 1.33% 0.51% 0.10% EBITDA - 17.67 8.87 6.26 2.71 1.25 EBITDA Margin - 26.06% 19.87% 19.75% 12.45% 12.99% Other Income - 3.14 2.20 1.15 0.60 0.16 Interest - 1.38 0.51 0.48 0.13 0.41 Depreciation - 1.53 0.77 0.36 0.20 0.14 PBT - 17.91 9.80 6.57 2.98 0.85 Tax - 4.85 2.76 0.56 -0.96 0.22 Tax Rate - 27.08% 28.16% 8.52% -32.21% 25.88% PAT - 13.05 7.04 6.01 3.95 0.63 PAT before Minority Interest - 13.05 7.04 6.01 3.95 0.63 Minority Interest - 0.00 0.00 0.00 0.00 0.00 PAT Margin - 19.25% 15.77% 18.96% 18.14% 6.55% PAT Growth - 85.37% 17.14% 52.15% 526.98% EPS - 11.25 6.07 5.18 3.41 0.54

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales - 86.96 44.63 31.69 21.77 Net Sales Growth - 94.85% 40.83% 45.57% Cost Of Goods Sold - 36.74 24.82 16.41 10.77 Gross Profit - 50.22 19.81 15.29 11.00 GP Margin - 57.75% 44.39% 48.25% 50.53% Total Expenditure - 71.95 36.39 25.43 19.06 Power & Fuel Cost - 1.36 0.26 0.10 0.02 % Of Sales - 1.56% 0.58% 0.32% 0.09% Employee Cost - 10.68 1.92 1.39 1.10 % Of Sales - 12.28% 4.30% 4.39% 5.05% Manufacturing Exp. - 11.13 6.26 4.64 4.63 % Of Sales - 12.80% 14.03% 14.64% 21.27% General & Admin Exp. - 4.93 0.91 0.71 0.81 % Of Sales - 5.67% 2.04% 2.24% 3.72% Selling & Distn. Exp. - 5.76 1.44 1.75 1.62 % Of Sales - 6.62% 3.23% 5.52% 7.44% Miscellaneous Exp. - 1.35 0.78 0.42 0.11 % Of Sales - 1.55% 1.75% 1.33% 0.51% EBITDA - 15.01 8.24 6.26 2.71 EBITDA Margin - 17.26% 18.46% 19.75% 12.45% Other Income - 8.23 2.08 1.16 0.60 Interest - 4.14 0.65 0.48 0.13 Depreciation - 5.49 0.97 0.36 0.20 PBT - 13.61 8.70 6.58 2.98 Tax - 3.12 2.76 0.56 -0.96 Tax Rate - 22.92% 31.72% 8.51% -32.21% PAT - 11.74 6.34 6.02 3.95 PAT before Minority Interest - 10.49 5.94 6.02 3.95 Minority Interest - 1.25 0.40 0.00 0.00 PAT Margin - 13.50% 14.21% 19.00% 18.14% PAT Growth - 85.17% 5.32% 52.41% EPS - 10.12 5.47 5.19 3.41

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 65.73 52.67 45.63 4.78 -0.47 Share Capital 11.50 11.50 11.50 8.00 5.00 Total Reserves 54.23 41.18 34.13 -3.22 -5.47 Non-Current Liabilities 6.93 3.51 0.01 0.45 2.73 Secured Loans 4.52 3.58 0.18 0.00 0.00 Unsecured Loans 1.88 0.00 0.27 1.42 4.53 Long Term Provisions 0.07 0.07 0.07 0.07 0.05 Current Liabilities 26.77 17.59 10.67 7.61 7.34 Trade Payables 9.65 7.58 4.81 5.23 4.02 Other Current Liabilities 5.21 5.44 2.78 1.28 3.25 Short Term Borrowings 7.64 2.17 2.51 0.60 0.00 Short Term Provisions 4.27 2.41 0.57 0.51 0.07 Total Liabilities 99.43 73.77 56.31 12.84 9.60 Net Block 14.80 7.62 3.11 1.43 1.18 Gross Block 18.26 9.55 4.27 2.23 1.77 Accumulated Depreciation 3.46 1.93 1.16 0.80 0.59 Non Current Assets 28.64 20.09 8.09 2.15 1.86 Capital Work in Progress 0.54 4.03 0.23 0.00 0.00 Non Current Investment 12.49 4.40 4.04 0.05 0.00 Long Term Loans & Adv. 0.82 4.04 0.71 0.67 0.68 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 Current Assets 70.77 53.66 48.18 10.69 7.74 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 16.57 11.06 7.17 3.71 5.27 Sundry Debtors 20.40 13.76 12.15 4.97 0.64 Cash & Bank 2.11 6.01 13.77 0.13 0.09 Other Current Assets 31.68 2.13 2.72 0.09 1.74 Short Term Loans & Adv. 30.08 20.71 12.38 1.79 1.73 Net Current Assets 44.00 36.07 37.52 3.08 0.40 Total Assets 99.43 73.77 56.30 12.84 9.60

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 64.46 52.90 45.63 4.78 Share Capital 11.50 11.50 11.50 8.00 Total Reserves 52.96 40.41 34.14 -3.22 Non-Current Liabilities 30.40 12.72 3.41 0.45 Secured Loans 19.39 8.81 2.75 0.00 Unsecured Loans 12.88 3.99 1.11 1.42 Long Term Provisions 0.07 0.07 0.07 0.07 Current Liabilities 55.20 20.94 11.86 7.62 Trade Payables 14.79 7.54 4.81 5.23 Other Current Liabilities 18.88 7.17 3.97 1.29 Short Term Borrowings 16.90 3.81 2.51 0.60 Short Term Provisions 4.64 2.43 0.57 0.51 Total Liabilities 155.25 87.61 62.37 12.85 Net Block 43.88 20.90 3.16 1.43 Gross Block 57.40 23.03 4.32 2.23 Accumulated Depreciation 13.53 2.14 1.16 0.80 Non Current Assets 60.60 32.99 12.18 2.10 Capital Work in Progress 1.60 4.03 4.83 0.00 Non Current Investment 10.72 3.77 3.34 0.00 Long Term Loans & Adv. 1.43 4.29 0.85 0.67 Other Non Current Assets 2.96 0.00 0.00 0.00 Current Assets 92.02 52.66 49.54 10.72 Current Investments 0.00 0.00 0.00 0.00 Inventories 28.24 12.58 7.17 3.71 Sundry Debtors 27.68 13.44 12.09 4.97 Cash & Bank 2.46 6.65 13.78 0.16 Other Current Assets 33.63 2.14 2.72 0.09 Short Term Loans & Adv. 31.75 17.84 13.78 1.79 Net Current Assets 36.82 31.72 37.68 3.10 Total Assets 155.25 87.62 62.39 12.85

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity -3.49 0.90 -16.60 -0.19 1.48 PBT 17.91 9.80 6.57 2.98 0.85 Adjustment 0.56 -0.53 0.08 0.33 0.55 Changes in Working Capital -17.71 -5.99 -22.72 -3.65 0.08 Cash after chg. in Working capital 0.76 3.28 -16.06 -0.33 1.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.25 -2.38 -0.54 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.14 0.00 Cash From Investing Activity -7.88 -11.01 -5.56 -0.50 -0.56 Net Fixed Assets -5.22 -9.08 -2.27 -0.46 Net Investments -8.09 -0.36 -3.99 -0.05 Others 5.43 -1.57 0.70 0.01 Cash from Financing Activity 7.47 2.35 35.80 0.80 -0.96 Net Cash Inflow / Outflow -3.90 -7.76 13.64 0.11 -0.03 Opening Cash & Equivalents 6.01 13.77 0.13 0.01 0.12 Closing Cash & Equivalent 2.11 6.01 13.77 0.13 0.09

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity -10.24 2.23 -19.00 -0.21 PBT 13.61 8.70 6.58 2.98 Adjustment 6.86 0.12 0.08 0.33 Changes in Working Capital -26.17 -4.20 -25.12 -3.67 Cash after chg. in Working capital -5.70 4.61 -18.46 -0.36 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -4.54 -2.38 -0.54 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.14 Cash From Investing Activity -13.82 -20.36 -9.69 -0.45 Net Fixed Assets -5.22 -9.08 -2.27 Net Investments -8.09 -0.36 -3.99 Others -0.51 -10.92 -3.43 Cash from Financing Activity 19.76 11.01 42.28 0.80 Net Cash Inflow / Outflow -4.31 -7.13 13.60 0.14 Opening Cash & Equivalents 6.65 13.78 0.18 0.01 Closing Cash & Equivalent 2.46 6.65 13.78 0.16

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 57.14 45.79 39.65 5.97 -0.94 ROA 15.07% 10.83% 17.39% 35.19% 9.08% ROE 22.05% 14.34% 23.87% 183.40% 0.00% ROCE 27.66% 19.11% 25.10% 55.11% 33.70% Fixed Asset Turnover 4.88 6.46 9.75 10.87 6.43 Receivable days 91.94 105.87 98.55 46.97 36.96 Inventory Days 74.38 74.50 62.65 75.32 117.74 Payable days 114.23 90.02 111.70 156.73 193.81 Cash Conversion Cycle 52.09 90.35 49.51 -34.45 -39.11 Total Debt/Equity 0.23 0.12 0.07 0.51 -9.61 Interest Cover 13.97 20.36 14.66 24.72 3.07

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 53.76 43.43 39.11 5.93 ROA 8.64% 7.92% 16.00% 30.72% ROE 18.78% 12.52% 24.21% 83.23% ROCE 19.17% 15.32% 23.60% 43.21% Fixed Asset Turnover 2.16 3.26 9.68 9.76 Receivable days 86.30 104.41 98.21 83.27 Inventory Days 85.68 80.77 62.65 62.24 Payable days 110.89 90.79 111.70 177.25 Cash Conversion Cycle 61.09 94.40 49.17 -31.74 Total Debt/Equity 0.87 0.37 0.17 0.52 Interest Cover 4.29 14.42 14.67 24.72

Top Investors:

nav capital vcc - nav capital emerging star fund

goenka business and finance limited

craft emerging market fund pcc- elite capital fund

chetan muktilal mehta huf

Annual Reports:

News Update:

Trident Lifeline acquires additional stake in Trident Mediquip
2nd Jan 2026, 09:28 AM

Pursuant to the above, the shareholding of the company in TML has increased from 51% to 60.04%
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback